Research highlights depression trends in community-dwelling older adults

Marked variation in the prevalence of depression was found in a multisite sample of community-dwelling older adults in the United States reports a study by Columbia University Mailman School of Public Health.

Research misconduct claims are growing. Will new rules help universities investigate them?

Amid a steady rise in research misconduct allegations over the past decade, the Department of Human Health and Services last week updated its guidance on

September 20, 2024

Enthusiasm for Transplant-Free Strategies for Low-Risk Relapsed Hodgkin Lymphoma

Non-transplant salvage therapy for low-risk relapsed/refractory pediatric classical Hodgkin lymphoma (cHL) had high rates of progression-free (PFS) and overall survival (OS) at 3-5 years, three

January 3, 2025

Risk Adjusted Net Present Value: What is the current valuation of Pfizer’s Atirmociclib

The revenue for Atirmociclib is expected to reach an annual total of $388 mn by 2040 globally based off GlobalData’s Revenue Model. The drug’s revenue

July 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.